125 related articles for article (PubMed ID: 2117255)
1. Changes in hepatic xenobiotic-metabolising enzymes in mouse liver following infection with Leishmania donovani.
Coombs GH; Wolf CR; Morrison VM; Craft JA
Mol Biochem Parasitol; 1990 Jun; 41(1):17-24. PubMed ID: 2117255
[TBL] [Abstract][Full Text] [Related]
2. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the hepatic microsomal cytochrome P-450 dependent mixed function oxidase activities in golden hamster during Leishmania donovani infection.
Singh AK; Tekwani BL; Guru PY; Rastogi AK; Pandey VC
Pharmacol Res; 1989; 21(5):507-12. PubMed ID: 2594607
[TBL] [Abstract][Full Text] [Related]
4. Xenobiotic-metabolizing enzymes in human respiratory nasal mucosa.
Gervasi PG; Longo V; Naldi F; Panattoni G; Ursino F
Biochem Pharmacol; 1991 Jan; 41(2):177-84. PubMed ID: 1989628
[TBL] [Abstract][Full Text] [Related]
5. Characterization, localization and regulation of a novel phenobarbital-inducible form of cytochrome P450, compared with three further P450-isoenzymes, NADPH P450-reductase, glutathione transferases and microsomal epoxide hydrolase.
Wolf CR; Moll E; Friedberg T; Oesch F; Buchmann A; Kuhlmann WD; Kunz HW
Carcinogenesis; 1984 Aug; 5(8):993-1001. PubMed ID: 6430587
[TBL] [Abstract][Full Text] [Related]
6. Application of hepatic cytochrome b
Reed L; Indra R; Mrizova I; Moserova M; Schmeiser HH; Wolf CR; Henderson CJ; Stiborova M; Phillips DH; Arlt VM
Toxicol Appl Pharmacol; 2019 Mar; 366():64-74. PubMed ID: 30685480
[TBL] [Abstract][Full Text] [Related]
7. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo[a]pyrene activation.
Gautier JC; Urban P; Beaune P; Pompon D
Eur J Biochem; 1993 Jan; 211(1-2):63-72. PubMed ID: 8425552
[TBL] [Abstract][Full Text] [Related]
8. Effects of perfluoro fatty acids on xenobiotic-metabolizing enzymes, enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver.
Permadi H; Lundgren B; Andersson K; DePierre JW
Biochem Pharmacol; 1992 Sep; 44(6):1183-91. PubMed ID: 1417940
[TBL] [Abstract][Full Text] [Related]
9. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
10. Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone.
Snyder R; Chepiga T; Yang CS; Thomas H; Platt K; Oesch F
Toxicol Appl Pharmacol; 1993 Oct; 122(2):172-81. PubMed ID: 8211999
[TBL] [Abstract][Full Text] [Related]
11. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
Wade AE; Evans JS; Holmes D; Baker MT
Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
[TBL] [Abstract][Full Text] [Related]
12. Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver.
Buchmann A; Kuhlmann W; Schwarz M; Kunz W; Wolf CR; Moll E; Friedberg T; Oesch F
Carcinogenesis; 1985 Apr; 6(4):513-21. PubMed ID: 3921270
[TBL] [Abstract][Full Text] [Related]
13. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
14. Effect of toluidines on drug metabolizing enzymes in rat liver, kidney and lung.
Gnojkowski J; Baer-Dubowska W; Klimek D; Chmiel J
Toxicology; 1984 Sep; 32(4):335-42. PubMed ID: 6435287
[TBL] [Abstract][Full Text] [Related]
15. Rat oesophageal cytochrome P450 (CYP) monooxygenase system: comparison to the liver and relevance in N-nitrosodiethylamine carcinogenesis.
Pinto LF; Moraes E; Albano RM; Silva MC; Godoy W; Glisovic T; Lang MA
Carcinogenesis; 2001 Nov; 22(11):1877-83. PubMed ID: 11698352
[TBL] [Abstract][Full Text] [Related]
16. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
17. Cytochromes P450 2B1 and P450 2B2 demethylate N-nitrosodimethylamine and N-nitrosomethylaniline in vitro.
Stiborová M; Hansíková H; Frei E
Gen Physiol Biophys; 1996 Jun; 15(3):211-23. PubMed ID: 9076504
[TBL] [Abstract][Full Text] [Related]
18. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
19. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
[TBL] [Abstract][Full Text] [Related]
20. Effect of chlorpromazine hydrochloride on carcinogen-metabolizing enzymes: liver microsomal dimethylnitrosamine demethylase, 4-dimethylaminoazobenzene reductase, and aryl hydrocarbon hydroxylase.
Mostafa MH; Weisburger EK
J Natl Cancer Inst; 1980 Apr; 64(4):925-9. PubMed ID: 6767870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
